Clinical Trial Update: Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers. [NA]

View source ↗

Summary

A clinical trial update reports that Samaritan Biologics is evaluating perinatal membrane allografts added to standard care for non-healing diabetic foot ulcers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Perinatal membrane allografts

Snippet

Sponsor: Samaritan Biologics | Conditions: Diabetic Foot Ulcer | NA | Status: RECRUITING